93 related articles for article (PubMed ID: 22726073)
1. A case of intraductal carcinoma with pleomorphic cells.
Cordoba A; Guerrero-Setas D; Vicente F; Mercado MR; Rodriguez I; Martinez-Peñuela JM
Pathol Int; 2012 Jul; 62(7):511-2. PubMed ID: 22726073
[No Abstract] [Full Text] [Related]
2. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
3. Is breast tumor progression really linear?
Polyak K
Clin Cancer Res; 2008 Jan; 14(2):339-41. PubMed ID: 18223205
[No Abstract] [Full Text] [Related]
4. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
Cornfield DB; Palazzo JP; Schwartz GF; Goonewardene SA; Kovatich AJ; Chervoneva I; Hyslop T; Schwarting R
Cancer; 2004 Jun; 100(11):2317-27. PubMed ID: 15160334
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast.
Park SS; Kim JE; Kim YA; Kim YC; Kim SW
Histopathology; 2005 Dec; 47(6):625-30. PubMed ID: 16324201
[TBL] [Abstract][Full Text] [Related]
6. Pleomorphic carcinoma of the breast with expression of macrophage markers: report of two cases.
Córdoba A; Del Rosario Mercado M; Vicente F; Ederra M; Torrea N; Guerrero-Setas D
Pathol Int; 2012 Jul; 62(7):491-5. PubMed ID: 22726069
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of expression of a 65 kDa oncofetal protein (p65), epidermal growth factor receptor (EGFR), oncogene c-erb B2 and tumor suppressor gene p53 protein products in breast cancer patients.
Niewiadomska H; Mirowski M; Stempień M; Błoński JZ; Czyz W; Switalska J; Matyga E; Hanausek M; Wierzbicki R
Neoplasma; 2000; 47(1):8-14. PubMed ID: 10870681
[TBL] [Abstract][Full Text] [Related]
8. Sarcomatoid breast tumors have sarcomatoid behavior.
Gilcrease MZ
Am J Surg Pathol; 2007 Feb; 31(2):326-7; author reply 327. PubMed ID: 17255781
[No Abstract] [Full Text] [Related]
9. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
10. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
Steinman S; Wang J; Bourne P; Yang Q; Tang P
Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
[TBL] [Abstract][Full Text] [Related]
11. Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas.
Domagala W; Harezga B; Szadowska A; Markiewski M; Weber K; Osborn M
Am J Pathol; 1993 Mar; 142(3):669-74. PubMed ID: 8384406
[TBL] [Abstract][Full Text] [Related]
12. Identification of a basal-like subtype of breast ductal carcinoma in situ.
Livasy CA; Perou CM; Karaca G; Cowan DW; Maia D; Jackson S; Tse CK; Nyante S; Millikan RC
Hum Pathol; 2007 Feb; 38(2):197-204. PubMed ID: 17234468
[TBL] [Abstract][Full Text] [Related]
13. Basal cell-specific and hyperproliferation-related keratins in human breast cancer.
Wetzels RH; Kuijpers HJ; Lane EB; Leigh IM; Troyanovsky SM; Holland R; van Haelst UJ; Ramaekers FC
Am J Pathol; 1991 Mar; 138(3):751-63. PubMed ID: 1705754
[TBL] [Abstract][Full Text] [Related]
14. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
[TBL] [Abstract][Full Text] [Related]
15. Intraductal carcinoma is the precursor of carcinoma ex pleomorphic adenoma and is often associated with dysfunctional p53.
Ihrler S; Weiler C; Hirschmann A; Sendelhofert A; Lang S; Guntinas-Lichius O; Arnold G; Zietz C; Harrison JD
Histopathology; 2007 Sep; 51(3):362-71. PubMed ID: 17593217
[TBL] [Abstract][Full Text] [Related]
16. Correlation of p53 and cerbB2 expression and hormonal receptor status with clinicopathologic parameters in ductal carcinoma in situ of the breast.
Tan PH; Chuah KL; Chiang G; Wong CY; Dong F; Bay BH
Oncol Rep; 2002; 9(5):1081-6. PubMed ID: 12168077
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society.
Iwase H; Kurebayashi J; Tsuda H; Ohta T; Kurosumi M; Miyamoto K; Yamamoto Y; Iwase T
Breast Cancer; 2010 Apr; 17(2):118-24. PubMed ID: 19466512
[TBL] [Abstract][Full Text] [Related]
18. Basal cytokeratin expression in relation to biological factors in breast cancer.
Kuroda H; Ishida F; Nakai M; Ohnisi K; Itoyama S
Hum Pathol; 2008 Dec; 39(12):1744-50. PubMed ID: 18755493
[TBL] [Abstract][Full Text] [Related]
19. DCIS and LCIS with multinucleated giant cells-a report of 4 cases.
Coyne JD
Histopathology; 2007 Apr; 50(5):669-71. PubMed ID: 17394507
[No Abstract] [Full Text] [Related]
20. p53 expression in intraductal epithelial hyperplasia, atypical intraductal hyperplasia, and intraductal carcinoma of the breast.
Fischler DF; Sebek BA; Tubbs RR; Biscotti CV
Histopathology; 1996 Jan; 28(1):93-4. PubMed ID: 8838130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
